RNase H-independent antisense activity of oligonucleotide N3'->P5' phosphoramidates

被引:56
|
作者
Heidenreich, O
Gryaznov, S
Nerenberg, M
机构
[1] NANOGEN,SAN DIEGO,CA 92121
[2] HANNOVER MED SCH,D-30623 HANNOVER,GERMANY
[3] LYNX THERAPEUT,HAYWARD,CA 94545
[4] MED BIOL INST,LA JOLLA,CA 92037
关键词
D O I
10.1093/nar/25.4.776
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oligonucleotide N3'-->P5' phosphoramidates are a new and promising class of antisense agents. Here we report biological properties of phosphoramidate oligonucleotides targeted against the human T cell leukemia virus type-1 Tax protein, the major transcriptional transactivator of this human retrovirus. Isosequential phosphorothioate oligodeoxynucleotides and uniformly modified and chimeric phosphoramidate oligodeoxynucleotides containing six central phosphodiester linkages are all quite stable in cell nuclei, The uniformly modified anti-tax phosphoramidate oligodeoxynucleotide does not activate nuclear RNase H, as was shown by RNase protection assay, In contrast, the chimeric phosphoramidate-phosphodiester oligodeoxynucleotide is an efficient activator of RNase H, The presence of one or two mismatched nucleotides in the phosphodiester portion of oligonucleotides affected this activation only negligibly, When introduced into tax-transformed fibroblasts ex vivo, only the uniformly modified anti-tax phosphoramidate oligodeoxynucleotide caused a sequence-dependent reduction in the Tax protein level, Neither the chimeric phosphoramidate nor the phosphorothioate oligodeoxynucleotides significantly reduced tax expression under similar experimental conditions.
引用
收藏
页码:776 / 780
页数:5
相关论文
共 50 条
  • [21] A remarkable stabilization of complexes formed by 2,6-diaminopurine oligonucleotide N3′→P5′ phosphoramidates.
    Matray, T
    Gamsey, S
    Pongracz, K
    Gryaznov, S
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2000, 19 (10-12): : 1553 - 1567
  • [22] Automated synthesis of oligonucleotide (N3'->P5') phosphoramidates using 3'-amino-2',3'-dideoxynucleoside phosphoramidites.
    Rao, TS
    Vu, H
    Akiyama, T
    Hogan, ME
    Ojwang, JO
    Rando, RF
    Revankar, GR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 62 - CARB
  • [23] Synthesis end properties of RNA analogs -: oligoribonucleotide N3′→P5′ phosphoramidates
    Matray, TJ
    Gryaznov, SM
    NUCLEIC ACIDS RESEARCH, 1999, 27 (20) : 3976 - 3985
  • [24] Convenient and efficient approach to Di- and trideoxyribonucleotide N3′→P5′ phosphoramidates
    Tang, X
    Huang, C
    Fu, H
    Zhao, YF
    SYNLETT, 2005, (12) : 1930 - 1932
  • [25] A new approach to oligonucleotide N3′→P5′ phosphoramidate building blocks
    Zielinska, D
    Pongracz, K
    Gryaznov, S
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2005, 24 (5-7): : 1063 - 1067
  • [26] A new approach to oligonucleotide N3′ → P5′ phosphoramidate building blocks
    Zielinska, Daria
    Pongracz, Krisztina
    Gryaznov, Sergei M.
    TETRAHEDRON LETTERS, 2006, 47 (26) : 4495 - 4499
  • [27] Morpholino antisense oligomers: the case for an RNase H-independent structural type
    Summerton, J
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01): : 141 - 158
  • [28] Synthetic oligonucleotides as RNA mimetics: 2′-modified RNAs and N3′→P5′ phosphoramidates
    M. Egli
    S. M. Gryaznov*
    Cellular and Molecular Life Sciences CMLS, 2000, 57 : 1440 - 1456
  • [29] Synthetic oligonucleotides as RNA mimetics:: 2′-modified RNAs and N3′→P5′ phosphoramidates
    Egli, M
    Gryaznov, SM
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (10) : 1440 - 1456
  • [30] Triple helix-tetraplex equilibrium for G-rich oligonucleotide N3′ → P5′ phosphoramidates:: role of molecular concentration and counterions
    Mondragón-Sánchez, JA
    Liquier, J
    Cheron, M
    Gryaznov, SM
    Taillandier, E
    JOURNAL OF MOLECULAR STRUCTURE, 2005, 748 (1-3) : 27 - 37